Marc Feldmann
Overview
Explore the profile of Marc Feldmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
154
Citations
9625
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hopewell S, Srikesavan C, Evans A, Er F, Rangan A, Preece J, et al.
BMJ Open
. 2024 May;
14(5):e078273.
PMID: 38692727
Objective: The Anti-Freaze-F (AFF) trial assessed the feasibility of conducting a definitive trial to determine whether intra-articular injection of adalimumab can reduce pain and improve function in people with pain-predominant...
2.
3.
Feldmann M, Maini R, Soriano E, Strand V, Takeuchi T
Nat Rev Rheumatol
. 2023 Nov;
19(12):761-766.
PMID: 37919339
No abstract available.
4.
Hopewell S, Kenealy N, Knight R, Rangan A, Dutton S, Srikesavan C, et al.
NIHR Open Res
. 2023 Oct;
2:28.
PMID: 37881307
Objectives: The Anti-Freaze-F trial will assess the feasibility of conducting a large randomised controlled trial to assess whether intra-articular injection of anti-TNF (adalimumab) can reduce pain and improve function in...
5.
Jensen L, Attfield K, Feldmann M, Fugger L
EBioMedicine
. 2023 Oct;
97:104840.
PMID: 37863021
JAK inhibitors impact multiple cytokine pathways simultaneously, enabling high efficacy in treating complex diseases such as cancers and immune-mediated disorders. However, their broad reach also poses safety concerns, which have...
6.
Lavi Y, Kogan N, Topping L, Liu C, McCann F, Williams R, et al.
J Med Chem
. 2023 Apr;
66(8):5536-5549.
PMID: 37057997
There is growing interest in non-psychoactive phytocannabinoids, namely cannabidiol (CBD), cannabigerol (CBG), and cannabichromene, as potential leads for novel therapeutic agents. In this study, we report on the development of...
7.
Bakinowska L, Vartak T, Phuthego T, Taylor M, Chandler K, Jerram S, et al.
Diabetes Care
. 2023 Jan;
46(4):714-721.
PMID: 36701208
Objective: Proteomic profiling can identify useful biomarkers. Monozygotic (MZ) twins discordant for a condition represent an ideal test population. We aimed to investigate and validate proteomic profiling in twins with...
8.
Chen S, Park M, Del Valle D, Buckup M, Tabachnikova A, Thompson R, et al.
Sci Transl Med
. 2022 Sep;
14(662):eabn5168.
PMID: 36103512
Although it has been more than 2 years since the start of the coronavirus disease 2019 (COVID-19) pandemic, COVID-19 continues to be a worldwide health crisis. Despite the development of...
9.
Nanchahal J, Ball C, Rombach I, Williams L, Kenealy N, Dakin H, et al.
Lancet Rheumatol
. 2022 Aug;
4(6):E407-E416.
PMID: 35949922
Background: Dupuytren's disease is a common fibrotic condition that causes the fingers to flex irreversibly into the palm. Treatments for late-stage disease all have limitations, and there is no approved...
10.
Robinson P, Liew D, Tanner H, Grainger J, Dwek R, Reisler R, et al.
Proc Natl Acad Sci U S A
. 2022 Apr;
119(15):e2119893119.
PMID: 35385354
The emergence of SARS-CoV-2 triggering the COVID-19 pandemic ranks as arguably the greatest medical emergency of the last century. COVID-19 has highlighted health disparities both within and between countries and...